|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's 2019 Pipeline Reportabout 7 years ago
High-Risk Marketing Violations Draw Scrutinyabout 7 years ago
Biopharma Business Checkabout 7 years ago
Patent Protection for Cannabis?about 7 years ago
Steadying the Path of Good Scienceabout 7 years ago
Southeast Biotech: Rising Tall in the Valleyabout 7 years ago
Fighting for a Streamlined European HTA Schemeabout 7 years ago
Stunted Innovation in Drug Development?over 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5